CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma.

Neuropathol Appl Neurobiol

Developmental Biology and Cancer Research and Teaching Department, Birth Defects Research Centre, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.

Published: August 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610141PMC
http://dx.doi.org/10.1111/nan.12613DOI Listing

Publication Analysis

Top Keywords

ctnnb1 mutations
4
mutations clonal
4
clonal adamantinomatous
4
adamantinomatous craniopharyngioma
4
ctnnb1
1
clonal
1
adamantinomatous
1
craniopharyngioma
1

Similar Publications

Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer.

World J Hepatol

January 2025

Shenzhen Branch, Guangdong Laboratory of Lingnan Modern Agriculture, Genome Analysis Laboratory of the Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen 518000, Guangdong Province, China.

In this review, we explore the application of next-generation sequencing in liver cancer research, highlighting its potential in modern oncology. Liver cancer, particularly hepatocellular carcinoma, is driven by a complex interplay of genetic, epigenetic, and environmental factors. Key genetic alterations, such as mutations in , , and , alongside epigenetic modifications such as DNA methylation and histone remodeling, disrupt regulatory pathways and promote tumorigenesis.

View Article and Find Full Text PDF

Desmoid-type fibromatosis (DTF) is a locally invasive tumor composed of myofibroblast-like cells and collagen; it does not metastasize but can cause significant local morbidity. Most sporadic cases are associated with mutations in the CTNNB1 gene, which encodes beta-catenin. Various treatments have been used with differing efficacy and toxicity profiles.

View Article and Find Full Text PDF

Purpose Of Review: Patients with cancer have an increased risk of venous thromboembolism (VTE). Guidelines suggest to use risk assessment tools to guide decisions about thromboprophylaxis, but current tools have modest discriminatory ability. Genetic information from the germline or tumor has the potential to improve VTE prediction.

View Article and Find Full Text PDF

CTNNB1 syndrome mouse models.

Mamm Genome

January 2025

The Gene Therapy Research Institute, CTNNB1 Foundation, Ljubljana, 1000, Slovenia.

CTNNB1 syndrome is a rare neurodevelopmental disorder, affecting children worldwide with a prevalence of 2.6-3.2 per 100,000 births and often misdiagnosed as cerebral palsy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!